Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to Oncology, Medical

Specialty Pharmacy Continuum

FDA Approves Adstiladrin, First Gene Therapy for Bladder Cancer

Clinical Pharmacology January 30th 2023

Journal of Experimental Medicine (JEM)

Microbiome Influencers of Checkpoint Blockade–associated Toxicity

Oncology, Medical January 23rd 2023


A Deep Dive into the Management of AEs Associated with ADCs

Oncology, Medical January 23rd 2023

OBR Oncology

“Eye-Popping” Results From Adding Venetoclax to CLIA in Newly Diagnosed AML

Hematology January 23rd 2023


Lymph Node Levels of the Neck

Oncology, Medical January 23rd 2023


Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone for Transplant-eligible Newly Diagnosed Multiple Myeloma: The GRIFFIN Trial

Hematology January 23rd 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form